Search

everythinglearnresearchcommunity

for

Search:↓

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

New compounds were made that are promising for prostate cancer therapy.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Teak leaf extract contains compounds that could help treat hair loss.

Angiogenin may help treat hair loss by reducing certain proteins in hair cells.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Finasteride and dutasteride can cause sexual problems like impotence and low libido.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

New compounds may help treat prostate cancer by reducing cell growth.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Hura crepitans and its compound daphne factor F3 may help treat hair loss by blocking a specific hair growth inhibitor.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Testosterone in our bodies helps increase insulin secretion from the pancreas.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Testosterone in human pancreas cells boosts insulin production.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.